Figure 4.
Sequential analyses of aROR of GI bleeding in apixaban, dabigatran, rivaroxaban, and warfarin in KIDS-KD 2012–2016.
Adjusted for age and gender; Vertical bars represent 95% CIs.
aROR, adjusted reporting odds ratio; CI, confidence interval; GI, gastrointestinal; KIDS-KD, Korea Institute of Drug Safety and Risk Management (KIDS)-Korea Adverse Event Reporting System (KAERS) database.